OncoRx Insights utilizes AI-driven analytics to streamline the integration of molecular diagnostic reports, enabling oncologists to make informed treatment decisions more efficiently. The platform addresses the issue of cancer patients receiving inappropriate treatments by providing real-time insights and alerts that match patient profiles with the most effective therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Oncologists face challenges in efficiently integrating complex molecular diagnostic reports from various labs, which can lead to delays in treatment decisions and potentially inappropriate therapies for cancer patients. Prior authorization processes further contribute to delays and administrative overhead.
Solution
OncoRx Insights is an AI-powered platform designed to streamline the integration of molecular diagnostic reports, providing oncologists with actionable insights to make faster, more informed treatment decisions. The platform aggregates reports from different labs into a unified, easily understood format, incorporating real-time research and trial data. By automating prior authorization and delivering curated pharmaceutical information, OncoRx Insights aims to improve patient outcomes, reduce treatment delays, and enhance collaboration among oncologists, pharmaceutical companies, and health plans. The system facilitates secure communication and virtual tumor board consults, while also offering insights and alerts to pharmaceutical companies based on oncologist decision processes and patient outcomes.
Target Audience
The primary target audience includes oncologists, pharmaceutical companies, and health plans seeking to improve the efficiency and effectiveness of cancer treatment decisions.
Features
- AI-driven analysis of molecular diagnostic reports from multiple labs
- Unified portal for diagnostic reports, research, and clinical trials
- Automated prior authorization processing
- Real-time alerts for molecular matches and treatment options
- Secure communication platform for oncologist collaboration and virtual tumor boards
- Curated pharmaceutical information delivery to oncologists
- Insights and data analytics for pharmaceutical companies based on treatment decisions and patient outcomes
- Integration of patient outcomes by molecular profile and prescribed drugs